NAPWA’s Treataware Project, a phone line, clinical trials website and booklet giving advice on treatments and living well with HIV, was launched by Dr Jonathan Anderson, President of ASHM on May 19 in Sydney.

Latest results presented by investigators at the CROI meeting in February in Boston suggested that treatment with abacavir (also found in the combination pills Kivexa and Trizivir) and ddI (didanosine, Videx) may significantly increase the risk of myocardial infarction, or heart attack.

Continuing improvements in HIV treatment are helping many people with HIV lead healthy lives, but some HIV-positive people may not be well-enough informed about the latest treatment options, the National Association of People Living with HIV/AIDS (NAPWA) has said in a statement to mark the launch of an innovative new HIV treatments information project.

Treataware, a suite of major NAPWA/ATPA treatments intitatives, will be launched in May 2008.

John Daye, NAPWA's Health, Treatments & Research Portfolio Co-Convenor reports from the 15th Conference on Retroviruses and Opportunistic Infections (CROI) held in Boston, USA from 3-6 February 2008

Australia's reputation as a world leader in HIV/AIDS treatment is at risk due to the failure of the Australian government to fund a key diagnostic test, the National Association of People Living with HIV/AIDS (NAPWA) has warned.

Following consultation with the Therapeutic Goods Administration, Roche Pharmaceuticals is undertaking a sponsor initiated recall of all batches and presentations of Viracept (Nelfinavir).

Gay men are being urgently warned to be sceptical of a genetic test being marketed in Australia which purports to indicate whether an individual may be immune to HIV infection.

The 16th International AIDS Conference highlighted numerous important and promising developments in HIV treatments. JOHN DAYE reports.

A report from the Health and Treatments Portfolio presented to the NAPWA Special General Meeting held 29-30 April 2006.